Association between gynecomastia and aromatase (CYP19) polymorphisms

European Journal of Endocrinology

Volumn 158, Issue 5, 2008, Pages 721-727

  Czajka Oraniec, Izabella ^a,d   Zgliczynski, Wojciech ^a   Kurylowicz, Alina ^b   Mikula, Michal ^c   Ostrowski, Jerzy ^c  

^a BIELANSKI HOSPITAL   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

^d HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CYSTEINE; THREONINE;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; EXON; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC RISK; GENOTYPE; GYNECOMASTIA; HORMONAL REGULATION; HUMAN; INCIDENCE; INTRON; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SHORT TANDEM REPEAT;

ADULT; AROMATASE; EXONS; GENETIC PREDISPOSITION TO DISEASE; GYNECOMASTIA; HUMANS; INCIDENCE; INTRONS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 43149113188     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0556     Document Type: Article

References (33)

1. Braunstein GD. Gynecomastia. New England Journal of Medicine 1993 328 490-495.
2. Braunstein GD. Aromatase and gynecomastia. Endocrine-Related Cancer 1999 6 315-324.
3. Simpson ER, Clyne C, Rubin G, Boon WC, Robertson K, Britt K, Speed C & Jones M. Aromatase - a brief overview. Annual Review of Physiology 2002 64 93-127.
4. Nydick M, Butos J, Dale JH & Rawson RW. Gynecomastia in adolescent boys. Journal of the American Medical Association 1961 178 449-454.
5. Wilson JD & Roehrborn C. Long-term consequences of castration in men: lessons from the Skoptzy and the eunuchs of the Chinese and Ottoman courts. Journal of Clinical Endocrinology and Metabolism 1999 84 4324-4331.
6. Li X, Warri A, Makela S, Ahonen T, Streng T, Santti R & Poutanen M. Mammary gland development in transgenic male mice expressing human P450 aromatase. Endocrinology 2002 143 4074-4083.
7. Shozu M, Sebastian S, Takayama K, Hsu W-T, Schultz RA, Neely K, Bryant M & Bulun SE. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. New England Journal of Medicine 2003 348 1855-1865.
8. Bulard J, Mowszowicz I & Schaison G. Increased aromatase activity in pubic skin fibroblasts from patients with isolated gynecomastia. Journal of Clinical Endocrinology and Metabolism 1987 64 618-623.
9. Griffin JE & Wilson JD. Abnormalities in estrogen metabolism. In Williams Textbook of Endocrinology, edn 10, pp 741-746. Eds PR Larsen, HM Kronenberg, S Melmed & KS Polonsky, Philadelphia: Saunders, 2003.
10. Ma CX, Adjei AA, Salavaggione OE, Coronel J, Pelleymounter L, Wang L, Eckloff BW, Schaid D, Wieben ED, Adjei AA & Weinshilboum RM. Human aromatase: gene resequencing and functional genomics. Cancer Research 2005 65 11071-11082.
11. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE & Ponder BA. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. Journal of the National Cancer Institute 2004 96 936-945.
12. Haiman CA, Hankinson SE, Spiegelman D, De Vivo I, Colditz GA, Willett WC, Speizer FE & Hunter DJ. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. International Journal of Cancer 2000 87 204-210.
13. Han DF, Zhou X, Hu MB, Xie W, Mao ZF, Chen DE, Liu F & Zheng F. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study. Chinese Medical Journal 2005 118 1507-1516.
14. Kristensen VN, Andersen TI, Lindblom A, Erikstein B, Magnus P & Borresen-Dale AL. A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics 1998 8 43-48.
15. Ahsan H, Whittemore AS, Chen Y, Senie RT, Hamilton SP, Wang Q, Gurvich I & Santella RM. Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study. Breast Cancer Research 2005 7 R71-R81.
16. Berstein LM, Imyanitov EN, Kovalevskij AJ, Maximov SJ, Vasilyev DA, Buslov KG, Sokolenko AP, Iyevleva AG, Chekmariova EV & Thijssen JH. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity. Cancer Letters 2004 207 191-196.
17. Arvanitis DA, Koumantakis GE, Goumenou AG, Matalliotakis IM, Koumantakis EE & Spandidos DA. CYP1A1, CYP19, and GSTM1 polymorphisms increase the risk of endometriosis. Fertility and Sterility 2003 79 702-709.
18. Gennari L, Masi L, Merlotti D, Picariello L, Falchetti A, Tanini A, Mavilia C, Del Monte F, Gonnelli S, Lucani B, Gennari C & Brandi ML. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. Journal of Clinical Endocrinology and Metabolism 2004 89 2803-2810.
19. Masi L, Becherini L, Gennari L, Amedei A, Colli E, Falchetti A, Farci M, Silvestri S, Gonnelli S & Brandi ML. Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk. Journal of Clinical Endocrinology and Metabolism 2001 86 2263-2269.
20. Van Pottelbergh I, Goemaere S & Kaufman JM. Bioavailable estriadol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age. Journal of Clinical Endocrinology and Metabolism 2003 88 3075-3081.
21. Riancho JA, Zarrabeitia MT, Valero C, Sanudo C, Hernandez JL, Amado JA, Zarrabeitia A & Gonzalez-Macias J. Aromatase gene and osteoporosis: relationship of ten polymorphic loci with bone mineral density. Bone 2005 36 917-925.
22. Kristensen VN, Harada N, Yoshimura N, Haraldsen E, Lonning PE, Erikstein B, Karesen R, Kristensen T & Borresen-Dale AL. Genetic variants of CYP19 (aromatase) and breast cancer risk. Oncogene 2000 19 1329-1333.
23. Niewoehner CB & Nuttal FQ. Gynecomastia in a hospitalized male population. American Journal of Medicine 1984 77 633-638.
24. Günhan-Bilgen I, Bozkaya H, Ustün EE & Memiş A. Male breast disease: clinical, mammographic, and ultrasonographic features. European Journal of Radiology 2002 43 246-255.
25. Polymeropoulos MH, Xiao H, Rath DS & Merril CR. Tetranucleotide repeat polymorphism at the human aromatase cytochrome P450 gene (CYP19). Nucleic Acids Research 1991 19 195.
26. Raymond M & Rousset F. GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. Journal of Heredity 1995 86 248-249.
27. Dick IM, Devine A & Prince RL. Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women. American Journal of Physiology. Endocrinology and Metabolism 2005 288 E989-E995.
28. Czajka-Oraniec I, Zgliczynski W, Puzianowska-Kuznicka M, Kurylowicz A, Mikula M & Ostrowski J. Role of c.454-351A/G polymorphism of estrogen receptor alpha gene in genetic predispsition to idiopathic gynecomastia. 5th Conference of the Section for Molecular Endocrinology of Polish Society of Endocrinology, 28-30 March 2007, Poznan, Poland.
29. Binder G, Iliev DI, Dufke A, Wabitsch M, Schweizer R, Ranke MB & Schmidt M. Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred. Journal of Clinical Endocrinology and Metabolism 2005 90 484-492.
30. Stratakis CA, Vottero A, Brodie A, Kirschner LS, DeAtkine D, Lu Q, Yue W, Mitsiades CS, Flor AW & Chrousos GP. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. Journal of Clinical Endocrinology and Metabolism 1998 83 1348-1357.
31. Thyagarajan B, Brott M, Mink P, Folsom AR, Anderson KE, Oetting WS & Gross M. CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study. Cancer Letters 2004 207 183-189.
32. Tworoger SS, Chubak J, Aiello EJ, Ulrich CM, Atkinson C, Potter JD, Yasui Y, Stapleton PL, Lampe JW, Farin FM, Stanczyk FZ & McTiernan A. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiology, Biomarkers and Prevention 2004 13 94-101.
33. Baghaei F, Rosmond R, Westberg L, Hellstrand M, Eriksson E, Holm G & Bjorntorp P. The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women. Obesity Research 2003 11 578-585.